Impact of quality of response on survival outcomes among multiple myeloma patients treated with novel agents – a retrospective analysis

BACKGROUND: In this era of target therapies, novel data on the correlation between response endpoints and survival outcomes in multiple myeloma have arisen. OBJECTIVE: To determine the impact of quality of response on clinical outcomes, using first-line treatment, and identify risk factors influenci...

Descripción completa

Detalles Bibliográficos
Autores principales: Ćojbašić, Irena, Vučić, Miodrag, Tijanić, Ivan, Ćojbašić, Žarko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Paulista de Medicina - APM 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610252/
https://www.ncbi.nlm.nih.gov/pubmed/35195237
http://dx.doi.org/10.1590/1516-3180.2021.0174.R2.22062021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610252/
https://www.ncbi.nlm.nih.gov/pubmed/35195237
http://dx.doi.org/10.1590/1516-3180.2021.0174.R2.22062021

Ejemplares similares